|
Diabetes, Vol 37, Issue 2 223-231, Copyright © 1988 by American Diabetes Association
Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics
C Cobelli and G Pacini
Institute of System Dynamics and Bioengineering (LADSEB), Italian National Research Council, Padova-Camin, Italy.
Methods for measuring insulin secretion and hepatic insulin extraction in
vivo, e.g., hepatic vein catheterization, are invasive, and can be applied
during steady state only. We introduce a noninvasive method for measuring
in vivo insulin secretion and its extraction by the liver during an
intravenous glucose tolerance test (IVGTT). This method is based on a
minimal model of C-peptide secretion and kinetics that is used for
interpreting plasma C-peptide concentration data during an IVGTT in normal
humans. The model allows the reconstruction of the time course of insulin
secretion and, used in conjunction with a minimal model of insulin delivery
and kinetics (described in a previous study), provides a noninvasive
measure of the time course of hepatic insulin extraction [H(t)]. The
C-peptide model also provides a direct prehepatic measure of beta-cell
sensitivity to glucose, expressed by two parameters related to first (phi
IC)- and second (phi IIC)-phase insulin secretion. In the 11 healthy
volunteers we studied, these parameters were 61 +/- 11 pM.min-1.mg-1.dl and
0.0154 +/- 0.0034 pM.min-2.mg-1.dl, respectively. H(t) showed an initial
decrement for approximately 30-50 min (from a fasting value of 63 +/- 8% to
a nadir of 53 +/- 9%) after the glucose stimulus, then a steady value of
approximately 62% was reestablished and maintained throughout the
experiment. The validity of the C-peptide model was further assessed by
comparing its estimate of the fractional plasma clearance rate (k01) with
that obtained in experiments in which biosynthetic human C-peptide was
administered.(ABSTRACT TRUNCATED AT 250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Toffolo, M. Campioni, R. Basu, R. A. Rizza, and C. Cobelli
A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction
Am J Physiol Endocrinol Metab,
January 1, 2006;
290(1):
E169 - E176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tura, G. Pacini, A. Kautzky-Willer, B. Ludvik, R. Prager, and K. Thomaseth
Basal and dynamic proinsulin-insulin relationship to assess {beta}-cell function during OGTT in metabolic disorders
Am J Physiol Endocrinol Metab,
July 1, 2003;
285(1):
E155 - E162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tura, B. Ludvik, J. J. Nolan, G. Pacini, and K. Thomaseth
Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT
Am J Physiol Endocrinol Metab,
November 1, 2001;
281(5):
E966 - E974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Guan, J. J. Matte, P. K. Ku, J. L. Snow, J. L. Burton, and N. L. Trottier
High Chromium Yeast Supplementation Improves Glucose Tolerance in Pigs by Decreasing Hepatic Extraction of Insulin
J. Nutr.,
May 1, 2000;
130(5):
1274 - 1279.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. D. Gaetano, G. Mingrone, M. Castagneto, and M. Calvani
Carnitine Increases Glucose Disposal in Humans
J. Am. Coll. Nutr.,
August 1, 1999;
18(4):
289 - 295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ahrén and G. Pacini
Age-Related Reduction in Glucose Elimination Is Accompanied by Reduced Glucose Effectiveness and Increased Hepatic Insulin Extraction in Man
J. Clin. Endocrinol. Metab.,
September 1, 1998;
83(9):
3350 - 3356.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Clodi, K. Thomaseth, G. Pacini, K. Hermann, A. Kautzky-Willer, W. Waldhausl, R. Prager, and B. Ludvik
Distribution and kinetics of amylin in humans
Am J Physiol Endocrinol Metab,
May 1, 1998;
274(5):
E903 - E908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rostami-Hodjegan, S. R. Peacey, E. George, S. R. Heller, and G. T. Tucker
Population-based modeling to demonstrate extrapancreatic effects of tolbutamide
Am J Physiol Endocrinol Metab,
April 1, 1998;
274(4):
E758 - E771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Watanabe, G. M. Steil, and R. N. Bergman
Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion
Am J Physiol Endocrinol Metab,
January 1, 1998;
274(1):
E172 - E183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ahren and G. Pacini
Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance
Am J Physiol Endocrinol Metab,
October 1, 1997;
273(4):
E701 - E707.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1988 by the American Diabetes Association.
|
|
| |
|